Soaanz Tablet, Film Coated
Product Images NDC 73502-586

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Soaanz (NDC 73502-586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sarfez Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Soanzxr 01)

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

This is a medication package insert and label. The medication is called Torsemide and contains 20mg of Oresenice USP. The recommended dosage is for SOAANZ®. The label includes information on storage, expiration date, manufacturer, and lot number.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

This appears to be a medication label. The medication is called torsemide and contains 20mg of oresemide USP. The recommended dosage and additional information can be found on the prescribing information. The medication should be stored between 2°C and 25°C, and kept away from children. The manufacturer is Saer Pramaceucals and the product has a GTIN and LOT number.*

FDA Label Image

Principal Display Panel (60 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (60 mg Tablet Bottle Label)

This text appears to be a mixture of product identification information, recommended dosage, and storage instructions. It also includes a reference to a pharmaceutical company and an area that is possibly for printing or labeling purposes. Without more context, it is not possible to generate a useful description from this text.*

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Exh fin-cote is a medicine containing 40 oresemice USP. The recommended dosage is prescribed by a physician and storage is between 21°C and 25°C (69-77°F) with limited exposure between 15°C and 36-86°F. Children should not take this medicine and its manufacture is done by Saz Ramaceucal. The medication is supplied in tablets under the brand name SOAANZ® and with the identification KRORUGSKTK2S 4802001. There is also information about the unvarnished area and measurements of GTIN and SN as well as the Lot and expiration date printed in the format of YYYY-MM.*

FDA Label Image

Principal Display Panel (20 mg Tablet Blister Pack Label)

FDA Label Image

Principal Display Panel (20 mg Tablet Blister Pack Carton)

This is a description for a medication called Torsemide. It contains 20mg of torsemide USP per tablet and comes in a package of 30 tablets, arranged in 5 blister cards with 6 tablets in each card, and requires a prescription. The recommended dosage and storage conditions are listed, and precautions for keeping it out of reach of children are mentioned. The manufacturer is Sarfez Pharmaceuticals Inc, located in Vienna, VA with a website at sarfez.com. The Lot No. and Expiration date are present, but the GTIN appears to be illegible.*

FDA Label Image

Principal Display Panel (40 mg Tablet Blister Pack Label)

FDA Label Image

Principal Display Panel (40 mg Tablet Blister Pack Carton)

This text is describing the medication "Torsemide" with a strength of 40 mg per tablet. It includes information such as recommended dosage, storage requirements, and packaging details. The medication is manufactured by Sarfez Pharmaceuticals in Vienna, VA.*

FDA Label Image

Principal Display Panel (60 mg Tablet Blister Pack Label)

FDA Label Image

Principal Display Panel (60 mg Tablet Blister Pack Carton)

This is a description of a medication called Sarfez® (torsemide) Tablets, which come in a pack of 30 tablets with each tablet consisting of 60mg of torsemide USP. The recommended dosage is not provided in this text, as the user is referred to the prescribing information. The tablets must be stored between 20°C and 25°C (68°F and 77°F) with excursions allowed between 15°C and 30°C (9°F and 86°F). The manufacturer is identified as Sarfez Pharmaceuticals Inc located in Vienna, VA 22182 USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.